The effects of sulpiride on psychomotor performance and subjective tolerance

European Neuropsychopharmacology

Volumn 7, Issue 3, 1997, Pages 219-223

  Meyer Lindenberg, A ^a,c   Rammsayer, T ^b   Ulferts, J ^a   Gallhofer, B ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b University Department of Psychology   (Germany)

^c Centre for Psychiatry   (Germany)

Author keywords

Cognitive performance; Healthy subjects; Psychomotor performance; Sulpiride

Indexed keywords

SULPIRIDE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DECISION MAKING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TIME PERCEPTION; VISUOMOTOR COORDINATION;

ACOUSTIC STIMULATION; ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FLICKER FUSION; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SULPIRIDE; TIME PERCEPTION;

EID: 0030999359     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00407-0     Document Type: Article

References (32)

1. Bartfai, A. and Wiesel, F.A. (1986) Effect of sulpiride on vigilance in healthy subjects. Int. J. Psychophysiol. 4, 1-5.
2. Brosteanu, E. and Floru, L. (1980) Untersuchung der visuell evozierten Potentiale bei schizophrenen Patienten unter einer Behandlung mit Sulpirid. Arzneimittel-Forsch. Drug Res. 30, 1306-1309.
3. Braynooghe, F., Geerts, S., van Maele, G. and Vögtle-Junkert, U. (1992) Behandlung reaktiver Depressionen mit Sulpirid. Fortschr. Fortbild. Med. 27, 498-502.
4. Caley, C.F. and Weber, S.S. (1995) Sulpiride: an antipsychotic with selective dopaminergic antagonist properties. Ann. Pharmacother. 29, 152-160.
5. Church, R.N. (1984) Properties of the internal clock. In Gibbon J. and Allan L.G. (eds) Timing and time perception, New York Academy of Science, New York, 566-582.
6. Fagan, D., Scott, D.B., Mitchell, M. and Tiplady, B. (1991) Effects of remoxipride on measures of psychological performance in healthy volunteers. Psychopharmacology 105, 225-229.
7. Farde, L., Wiesel, F., Nordström, A. and Sedvall, G. (1989) D1- and D2-receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99, S28-S31.
8. Fraisse, P. (1979) Influence de la durée du traitement de l'information sur l'estimation d'une durée d'une seconde. Année Psychologique 79, 495-504.
9. Görtelmeyer, R. and Wiemann, H. (1982) Retest reliability and construct validity of critical flicker fusion frequency. Pharmacopsychiatry 15 (Suppl. 1), 24-28.
10. Goldstone, S. and Lhamon, W.T. (1976) The effects of haloperidol upon temporal information processing by patients with Tourette's syndrome. Psychopharmacology 50, 7-10.
11. Goldstone, S., Nurnberg, H.G. and Lhamon, W.T. (1979) Effects of trifluoperazine, chlorpromazine, and haloperidol upon temporal information processing by schizophrenic patients. Psychopharmacology 65, 119-124.
12. Hindmarch, I. (1982) Critical flicker fusion frequency (CFF): the effects of psychotropic compounds. Pharmacopsychiatry 15 (Suppl. 1), 44-48.
13. Hindmarch, I. and Bhatti, J.Z. (1988) Psychopharmacological effects of sertraline in normal, healthy volunteers. Eur. J. Clin. Pharmacol. 35, 221-223.
14. Holmberg, G. (1982) The effects of anxiolytics on CFF. Pharmacopsychiatry 15 (Suppl. 1), 49-53.
15. Jenner, P. and Marsden, C.D. (1984) Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs. Acta Psychiatr. Scand. 311, 109-123.
16. Jenner, P. and Marsden, C.D. (1985) Das neuropharmakologische Profil von Dogmatil. Sem. Hop. 61, 1289-1296.
17. Laux, G. and Broich, K. (1994) Sulpirid-ein atypisches Neurothymoleptikum. Fundamenta Psychiatrica 8, 50-59.
18. Levander, S.E. (1982) Computerized CFF: reliability and validity of two psychophysical techniques. Pharmacopsychiatry 15 (Suppl. 1), 21-23.
19. Levitt, H. (1971) Transformed up-down methods in psychoacoustics. J. Acoust. Soc. Am. 49, 467-477.
20. Mulligan, R.M. and Schiffman, H.R. (1979) Temporal experience as a function of organization in memory. Bull. Psychonom. Soc. 14, 417-420.
21. Ornstein, R.E. (1969) On the experience of time. Penguin Books, Harmondsworth.
22. Poynter, W.D. and Homa, D. (1983) Duration judgment and the experience of change. Percept. Psychophys. 33, 548-560.
23. Rammsayer, T. (1989a) Dopaminergic and serotoninergic influence on duration discrimination and vigilance. Pharmacopsychiatry 22 (Suppl.), 39-43.
24. Rammsayer, T. (1989b) Is there a common dopaminergic basis of time perception and reaction time? Neuropsychobiol. 21, 37-42.
25. Rammsayer, T. and Lima, S. (1991) Duration discrimination of filled and empty auditory intervals: cognitive and perceptual factors. Percept. Psychophys. 50, 565-574.
26. Rammsayer, T. and Gallhofer, B. (1995) Remoxipride versus haloperidol in healthy volunteers: psychometric and subjective tolerance profiles. Int. J. Clin. Psychopharmacol. 10, 31-37.
27. Seppala, T. (1976) Effect of chlorpromazine or sulpiride and alcohol on psychomotor skills related to driving. Arch. Int. Pharmacodyn. Ther. 223, 311-323.
28. Seppala, T., Saario, I. and Mattila, M.J. (1976) Two weeks' treatment with chlorpromazine, thioridazine, sulpiride, or bromazepam: actions and interactions with alcohol on psychomotor skills related to driving. Mod. Probl. Pharmacopsychiatry 11, 85-90.
29. Smith, J.M. and Misiak, H. (1976) Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects. - A review. Psychopharmacology 47, 175-182.
30. Standish-Barry, H., Bouras, N., Bridges, P. and Watson, J. (1983) A randomized double-blind group comparative study of sulpiride and amitriptyline in affective disorder. Psychopharmacology 81, 258-260.
31. Ungerstedt, U., Herrera-Marschitz, M., Sharp, T., Stähle, L., Tossmann, U. and Zetterström, T. (1985) Pharmakologische Charakterisierung von Dogmatil. Prä- und postsynaptische Wirkungen auf die Dopaminrezeptoren. Sem. Hop. 61, 1283-1287.
32. Wiesel, F.A., Alfredson, G., Ehrnebo, M. and Sedvall, G. (1980) The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Eur. J. Clin. Pharmacol. 17, 385-391.